Aberdeen Group’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $47.7M | Sell |
200,653
-38,483
| -16% | -$8M | 0.07% | 238 |
|
|
2026
Q1 | $50.5M | Buy |
239,136
+4,067
| +2% | +$876K | 0.08% | 210 |
|
|
2025
Q4 | $48.3M | Buy |
235,069
+2,335
| +1% | +$439K | 0.07% | 216 |
|
|
2025
Q3 | $36M | Buy |
232,734
+3,274
| +1% | +$506K | 0.06% | 277 |
|
|
2025
Q2 | $38.5M | Buy |
229,460
+28,520
| +14% | +$4.23M | 0.07% | 251 |
|
|
2025
Q1 | $27.6M | Sell |
200,940
-520,475
| -72% | -$66.3M | 0.05% | 306 |
|
|
2024
Q4 | $85.4M | Sell |
721,415
-3,529
| -0.5% | -$412K | 0.16% | 136 |
|
|
2024
Q3 | $79.9M | Buy |
724,944
+16,569
| +2% | +$1.73M | 0.15% | 156 |
|
|
2024
Q2 | $69.6M | Buy |
708,375
+33,216
| +5% | +$3.38M | 0.13% | 163 |
|
|
2024
Q1 | $75.6M | Buy |
675,159
+569,235
| +537% | +$61.4M | 0.15% | 156 |
|
|
2023
Q4 | $10.7M | Sell |
105,924
-50,477
| -32% | -$5.01M | 0.02% | 536 |
|
|
2023
Q3 | $13.6M | Sell |
156,401
-52,400
| -25% | -$4.74M | 0.03% | 381 |
|
|
2023
Q2 | $19.7M | Sell |
208,801
-209,993
| -50% | -$17.7M | 0.05% | 346 |
|
|
2023
Q1 | $31.6M | Sell |
418,794
-96,204
| -19% | -$7.26M | 0.08% | 254 |
|
|
2022
Q4 | $39.6M | Buy |
514,998
+47,492
| +10% | +$3.61M | 0.11% | 208 |
|
|
2022
Q3 | $31.2M | Buy |
467,506
+255,044
| +120% | +$16.2M | 0.09% | 232 |
|
|
2022
Q2 | $11.2M | Buy |
212,462
+32,483
| +18% | +$1.85M | 0.04% | 397 |
|
|
2022
Q1 | $10.3M | Buy |
179,979
+4,591
| +3% | +$246K | 0.03% | 442 |
|
|
2021
Q4 | $9.03M | Sell |
175,388
-8,523
| -5% | -$418K | 0.02% | 510 |
|
|
2021
Q3 | $9.17M | Sell |
183,911
-2,712
| -1% | -$147K | 0.02% | 512 |
|
|
2021
Q2 | $10.7M | Sell |
186,623
-7,805
| -4% | -$456K | 0.02% | 485 |
|
|
2021
Q1 | $11.8M | Sell |
194,428
-34,235
| -15% | -$1.89M | 0.03% | 457 |
|
|
2020
Q4 | $12.2M | Buy |
228,663
+35,538
| +18% | +$1.84M | 0.03% | 418 |
|
|
2020
Q3 | $9.07M | Sell |
193,125
-16,183
| -8% | -$830K | 0.02% | 448 |
|
|
2020
Q2 | $10.9M | Sell |
209,308
-10,114
| -5% | -$521K | 0.03% | 395 |
|
|
2020
Q1 | $10.5M | Buy |
219,422
+7,095
| +3% | +$368K | 0.03% | 381 |
|
|
2019
Q4 | $10.7M | Sell |
212,327
-175,928
| -45% | -$9.09M | 0.03% | 440 |
|
|
2019
Q3 | $18.3M | Sell |
388,255
-216,024
| -36% | -$9.86M | 0.05% | 338 |
|
|
2019
Q2 | $28.5M | Buy |
604,279
+285,162
| +89% | +$13.2M | 0.06% | 288 |
|
|
2019
Q1 | $15.4M | Buy |
319,117
+40,691
| +15% | +$2.04M | 0.03% | 415 |
|
|
2018
Q4 | $12.4M | Buy |
278,426
+13,195
| +5% | +$688K | 0.03% | 412 |
|
|
2018
Q3 | $14.3M | Buy |
265,231
+12,966
| +5% | +$664K | 0.03% | 438 |
|
|
2018
Q2 | $12.3M | Buy |
252,265
+27,307
| +12% | +$1.55M | 0.02% | 452 |
|
|
2018
Q1 | $14.1M | Buy |
224,958
+30,445
| +16% | +$2.09M | 0.03% | 400 |
|
|
2017
Q4 | $11.9M | Buy |
194,513
+9,961
| +5% | +$616K | 0.02% | 435 |
|
|
2017
Q3 | $12.4M | Buy |
+184,552
| New | +$13M | 0.02% | 423 |
|
Other funds holding CAH
Aberdeen Group's CAH Position: Q2 2026 in Review
Aberdeen Group reduced its Cardinal Health (CAH) stake by 16% in Q2 2026, selling an estimated $8M and leaving 200,653 shares worth $47.7M. The position accounts for 0.07% of the portfolio, ranked #238.
Aberdeen Group first reported a position in CAH in Q3 2017 and has held it in 36 quarters since. The position peaked at $85.4M in Q4 2024. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Aberdeen Group held 200,653 shares of Cardinal Health worth $47.7M as of Q2 2026.
- Aberdeen Group sold 38,483 Cardinal Health shares in Q2 2026, an estimated $8M.
- Cardinal Health made up 0.07% of Aberdeen Group's portfolio in Q2 2026, its #238 holding.
- Aberdeen Group first reported a position in Cardinal Health in Q3 2017 and has held it in 36 quarters since.
- Aberdeen Group's Cardinal Health position peaked at $85.4M in Q4 2024.
- 1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.